期刊文献+

阿司匹林调节小鼠腹腔巨噬细胞MMP-2/9和TIMP-1基因的表达及分泌 被引量:1

Modulation of Aspirin on Gene Expression and Release of MMP-2/9 and TIMP-1 in Macrophages of Mice
原文传递
导出
摘要 目的研究阿司匹林对小鼠腹腔巨噬细胞基质金属蛋白酶(MMP)-2/9和基质金属蛋白酶组织抑制因子-1(TIMP-1)基因表达及分泌的影响。方法培养的小鼠腹腔巨噬细胞用阿司匹林处理后,用RT-PCR方法检测MMP-2/9和TIMP-1mRNA表达,用ELISA方法测定培养上清液中MMP-2/9和TIMP-1的含量。结果小鼠腹腔巨噬细胞经用阿司匹林12.5~50μg/ml处理24h后,MMP-2/9mRNA表达及分泌至培养上清液中的含量明显降低,MMP-2的降低百分率分别为18.6%~86.8%和37.7%~53.3%,MMP-9的降低百分率分别为32.1%~78.3%和6.5%~14.3%;而TIMP-1mRNA的表达及分泌却显著提高,其增加百分率分别为60.5%~110.9%和94.4%~80.6%。结论阿司匹林可抑制MMP-2/9的基因表达及分泌,同时还可增加TIMP-1的基因表达及分泌,这一效应对增加动脉粥样硬化斑块的稳定性和预防心血管事件的发生具有有利的作用。 Objective To investigate whether aspirin affected the MMP-2/9 and TIMP-1 gene expression and release in cultured macrophages of mice. Methods The mRNA expression of MMP-2/9 and TIMP-1 was determined by reverse transcription-polymerase chain reaction, while the protein level of MMP-2/9 and TIMP-1 in cultured cell supernatants was determined by enzyme linked immunosorbent assay after mouse celiac macrophages were treated with aspirin. Results The mRNA expression and protein level of MMP-2/9 was decreased after treatment with aspirin 12.5-50 μg/ml for 24 h, the decreased percentage was 18.6%-86.8%(mRNA expression) and 37.7%-53.3% (protein level) for MMP-2, 32.1%-78.3%(mRNA expression) and 6.5% -14.3% (protein level) for MMP-9, respectively. While the mRNA expression and protein level of TIMP-1 were inversely increased, the increased percentage was 60.5%-110.9%(mRNA expression) and 94.4%-80.6% (protein level), respectively. Conclusion Aspirin can inhibit the gene expression and release of MMP-2/9, and increase the gene expression and release of TIMP-1, and the effects might be good for the stabilization of atheroselerotic plaques and prevention of cardiovascular events.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2009年第3期422-425,共4页 Suzhou University Journal of Medical Science
基金 江苏省自然科学基金资助项目(BK2005029)
关键词 阿司匹林 MMP-2 MMP-9 TIMP-1 巨噬细胞 小鼠 aspirin MMP-2 MMP-9 TIMP-1 macrophages mice
  • 相关文献

参考文献10

  • 1Mehta P. Aspirin in the prophylaxis of coronary artery disease[J]. Curr Opin Cardiol, 2002, 17(5):552-558.
  • 2Karna E, Palka JA. Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation [J]. Eur J Pharmacol, 2002, 443(1-3):1-6.
  • 3Murono S, Yoshizaki T, Sato H, et al. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein-1 through suppression of matrix metalloproteinase-9 expression[J]. Cancer Res, 2000, 60(9): 2555-2561.
  • 4薛洁,华轶男,顾振纶,吴开云,谢梅林.阿司匹林抑制兔腹主动脉粥样斑块破裂及MMP-2表达的研究[J].中国药理学通报,2008,24(10):1335-1339. 被引量:4
  • 5Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly[J]. Circ Res, 2002, 90(3):251-262.
  • 6Galls ZS, Johnson C, Godin D, et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling[J]. Circ Res, 2002, 91(9):852-859.
  • 7Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury[J]. Circ Res, 2002; 91(9): 845-851.
  • 8Orbe J, Fernandez L, Rodriguez JA, et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions: relation to plaque features and vascular bed [J]. Atheroselerosis, 2003, 170(2):269-276.
  • 9Lemaitre V, Soloway PD, D'Armiento J. Increased medial degradation with pseudo -aneurysm formation in apolipoprotein E-knockout mice deficient in tissue in- hibitor of metalloproteinases-1[J]. Circulation, 2003, 107 (2):333-338.
  • 10Clark IM, Swingler TE, Sampieri CL, et al. The regulation of matrix metalloproteinases and their inhibitors[J], lnt J Biochem Cell Biol, 2008, 40(6-7):1362-1378.

二级参考文献17

  • 1蔡宝祥,谢梅林,顾振纶.兔动脉粥样硬化斑块破裂模型的实验研究[J].上海实验动物科学,2004,24(4):200-203. 被引量:4
  • 2夏效东,凌文华.动脉粥样硬化不稳定斑块的研究现状[J].中国心血管杂志,2005,10(2):139-141. 被引量:11
  • 3王涛,浦艳华,殷洁,贾如意.易损斑块与急性冠脉综合征[J].心血管病学进展,2007,28(2):246-248. 被引量:13
  • 4吴伟,齐若梅,李睿,高欣,鲍利.阿司匹林抑制ox-LDL诱导内皮细胞炎症分子表达的研究[J].中国药理学通报,2007,23(4):472-475. 被引量:8
  • 5Kuzuya M, Iguchi A. Role of matrix metalloproteinase in vascular remodeling[ J ]. J Atheroscler Thromb ,2003 ,10 ( 5 ) :275 - 82.
  • 6Antithrombotie Trialists'Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction,and stroke in high risk patients [ J ]. Br Med J,2002,324 : 71 - 86.
  • 7Karna E,Palka J A. Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation[J]. Eur J Pharmacol,2002,443:1 -6.
  • 8Mehta J L, Chen J, Yu F, et al. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial ceils [ J ]. Cardiovasc Res,2004,64:243 - 9.
  • 9Sano K, Kawasaki M, Ishihara Y, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound [ J ]. J Am Coll Cardiol, 2006,47 : 734 - 41.
  • 10Myoishi M, Hao H, Minarnino T,et al. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with aetue coronary syndrome[ J]. Circulation ,2007,116 : 1226 - 33.

共引文献3

同被引文献10

  • 1于小红,瞿玲慊,钮红音,姜敏辉,刘毅.高血压病患者合并颈动脉粥样硬化与血清高敏C反应蛋白的相关性研究[J].苏州大学学报(医学版),2005,25(6):1038-1040. 被引量:3
  • 2Kuge Y, Takai N, Ishino S, et al. Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP) , matrix metalioproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis[J]. Biol Pharm Bull, 2007,30 (9) :1634 - 1640.
  • 3Zureik M, Beaudeux JL, Courbon D,et al. Serum tissue inhibitors of metalloproteinases 1 ( TIMP-1 ) and carotid atherosclerosis and aortic arterial stiffness [J]. J Hypertens, 2005,23 (12) :2263 - 2268.
  • 4Jose RR, Ramachandran SV, Alexa SB, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the framingham off- spring study[ J ]. J Stroke Cerebrovasc Dis,2008,17 ( 6 ) : 412 - 417.
  • 5Kumada M, Kihara S, Ouchi N, et al. Adiponectin speci- fically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages [J]. Circulation,2004,109 ( 17 ) : 2046 - 2049.
  • 6Galia ZS, Mmnwki M,Sakhova GK,et al. Enhanced exprsssion of vascular matrixmetallopo-teinases in vitro by cytokines and in regions of human atherosclerotic lesions [ J ]. Ann NY Acad Sci, 1995,748 ( 3 ) :501 - 507.
  • 7Galis ZS, Sukhova GK, Kranzhofer R, et al. Mactrophag foam cells fiom experimental atheroma constitutively produce matridegrading proteinase [ J ]. Proc Natl Acad Sci USA, 1995,92 (2) : 402 - 406.
  • 8Basu P, Sen U, Tyagi T, et al. Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function [J]. Vascular Health and Risk Management, 2010,6(3):215 - 228.
  • 9Nanni S, Melandri G, Hanemaaijer R, et al. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms [ J ]. Transl Res,2007,149 ( 3 ) : 137 - 144.
  • 10苏伟,高枫,龚少愚,张亦哲,陆曙.原发性高血压患者血清基质金属蛋白酶9与升主动脉弹性的关系[J].中华高血压杂志,2010,18(4):385-389. 被引量:12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部